Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 162

1.

Methylglyoxal Acts as a Tumor-Promoting Factor in Anaplastic Thyroid Cancer.

Antognelli C, Moretti S, Frosini R, Puxeddu E, Sidoni A, Talesa VN.

Cells. 2019 Jun 6;8(6). pii: E547. doi: 10.3390/cells8060547.

2.

Synaptic vesicle protein 2A tumoral expression predicts levetiracetam adverse events.

Romoli M, Mandarano M, Romozzi M, Eusebi P, Bedetti C, Nardi Cesarini E, Verzina A, Calvello C, Loreti E, Sidoni A, Giovenali P, Calabresi P, Costa C.

J Neurol. 2019 Jun 5. doi: 10.1007/s00415-019-09410-0. [Epub ahead of print]

PMID:
31168673
3.

Immune Profiling of Thyroid Carcinomas Suggests the Existence of Two Major Phenotypes: an ATC-like and a PDTC-like.

Giannini R, Moretti S, Ugolini C, Macerola E, Menicali E, Nucci N, Morelli S, Colella R, Mandarano M, Sidoni A, Panfili M, Basolo F, Puxeddu E.

J Clin Endocrinol Metab. 2019 Mar 18. pii: jc.2018-01167. doi: 10.1210/jc.2018-01167. [Epub ahead of print]

PMID:
30882858
4.

Early stage resectable non-small cell lung cancer: is neoadjuvant immunotherapy the right way forward?

Chiari R, Sidoni A, Metro G.

J Thorac Dis. 2018 Nov;10(Suppl 33):S3890-S3894. doi: 10.21037/jtd.2018.10.22. No abstract available.

5.

KRAS mutation and DNA repair and synthesis genes in non-small-cell lung cancer.

Ludovini V, Ricciuti B, Tofanetti FR, Mencaroni C, Giannarelli D, Sidoni A, Reda MS, Siggillino A, Baglivo S, Crinò L, Bellezza G, Chiari R, Metro G.

Mol Clin Oncol. 2018 Dec;9(6):689-696. doi: 10.3892/mco.2018.1731. Epub 2018 Oct 1.

6.

Assessment of TILs, IDO-1, and PD-L1 in resected non-small cell lung cancer: an immunohistochemical study with clinicopathological and prognostic implications.

Mandarano M, Bellezza G, Belladonna ML, Van den Eynde BJ, Chiari R, Vannucci J, Mondanelli G, Ludovini V, Ferri I, Bianconi F, Del Sordo R, Cagini L, Albini E, Metro G, Puma F, Sidoni A.

Virchows Arch. 2019 Feb;474(2):159-168. doi: 10.1007/s00428-018-2483-1. Epub 2018 Nov 17.

PMID:
30448912
7.

Osimertinib.

Malapelle U, Ricciuti B, Baglivo S, Pepe F, Pisapia P, Anastasi P, Tazza M, Sidoni A, Liberati AM, Bellezza G, Chiari R, Metro G.

Recent Results Cancer Res. 2018;211:257-276. doi: 10.1007/978-3-319-91442-8_18. Review.

PMID:
30069773
8.

Long-term survival with erlotinib in advanced lung adenocarcinoma harboring synchronous EGFR G719S and KRAS G12C mutations.

Ricciuti B, Baglivo S, Ludovini V, Sidoni A, Metro G, Brambilla M, Siggillino A, Reda MS, Rebonato A, Maiettini D, Chiari R.

Lung Cancer. 2018 Jun;120:70-74. doi: 10.1016/j.lungcan.2018.04.002. Epub 2018 Apr 3.

PMID:
29748019
9.

IL-9 and Mast Cells Are Key Players of Candida albicans Commensalism and Pathogenesis in the Gut.

Renga G, Moretti S, Oikonomou V, Borghi M, Zelante T, Paolicelli G, Costantini C, De Zuani M, Villella VR, Raia V, Del Sordo R, Bartoli A, Baldoni M, Renauld JC, Sidoni A, Garaci E, Maiuri L, Pucillo C, Romani L.

Cell Rep. 2018 May 8;23(6):1767-1778. doi: 10.1016/j.celrep.2018.04.034.

10.

Anaplastic lymphoma kinase immunohistochemistry scores do not predict sensitivity to crizotinib in fluorescence in situ hybridization-positive non-small cell lung cancer patients.

Metro G, Giannarelli D, Sidoni A, Chiari R, Bellezza G.

Int J Biol Markers. 2018 Apr 1:1724600818754763. doi: 10.1177/1724600818754763. [Epub ahead of print] No abstract available.

PMID:
29683065
11.

Precision medicine against ALK-positive non-small cell lung cancer: beyond crizotinib.

Ricciuti B, De Giglio A, Mecca C, Arcuri C, Marini S, Metro G, Baglivo S, Sidoni A, Bellezza G, Crinò L, Chiari R.

Med Oncol. 2018 Apr 17;35(5):72. doi: 10.1007/s12032-018-1133-4. Review.

PMID:
29666949
12.

Human Umbilical Cord Wharton Jelly-Derived Adult Mesenchymal Stem Cells, in Biohybrid Scaffolds, for Experimental Skin Regeneration.

Montanucci P, di Pasquali C, Ferri I, Pescara T, Pennoni I, Siccu P, Sidoni A, Cervelli V, Basta G, Calafiore R.

Stem Cells Int. 2017;2017:1472642. doi: 10.1155/2017/1472642. Epub 2017 Dec 31.

13.

Mouse Thyroid Gland Changes in Aging: Implication of Galectin-3 and Sphingomyelinase.

Traina G, Cataldi S, Siccu P, Loreti E, Ferri I, Sidoni A, Codini M, Gizzi C, Sichetti M, Ambesi-Impiombato FS, Beccari T, Curcio F, Albi E.

Mediators Inflamm. 2017;2017:8102170. doi: 10.1155/2017/8102170. Epub 2017 Dec 11.

14.

Nephrotic syndrome in primary myelofibrosis with renal extramedullary hematopoiesis and glomerulopathy in the JAK inhibitor era.

Del Sordo R, Brugnano R, Covarelli C, Fiorucci G, Falzetti F, Barbatelli G, Nunzi E, Sidoni A.

Clin Nephrol Case Stud. 2017 Jul 24;5:70-77. doi: 10.5414/CNCS109100. eCollection 2017.

15.

VDR independent induction of acid-sphingomyelinase by 1,23(OH)2 D3 in gastric cancer cells: Impact on apoptosis and cell morphology.

Albi E, Cataldi S, Ferri I, Sidoni A, Traina G, Fettucciari K, Ambesi-Impiombato FS, Lazzarini A, Curcio F, Ceccarini MR, Beccari T, Codini M.

Biochimie. 2018 Mar;146:35-42. doi: 10.1016/j.biochi.2017.11.011. Epub 2017 Nov 20.

PMID:
29158006
16.

Prognostic implication of aquaporin 1 overexpression in resected lung adenocarcinoma.

Bellezza G, Vannucci J, Bianconi F, Metro G, Del Sordo R, Andolfi M, Ferri I, Siccu P, Ludovini V, Puma F, Sidoni A, Cagini L.

Interact Cardiovasc Thorac Surg. 2017 Dec 1;25(6):856-861. doi: 10.1093/icvts/ivx202.

PMID:
29106595
17.

ROC-king onwards: intraepithelial lymphocyte counts, distribution & role in coeliac disease mucosal interpretation.

Rostami K, Marsh MN, Johnson MW, Mohaghegh H, Heal C, Holmes G, Ensari A, Aldulaimi D, Bancel B, Bassotti G, Bateman A, Becheanu G, Bozzola A, Carroccio A, Catassi C, Ciacci C, Ciobanu A, Danciu M, Derakhshan MH, Elli L, Ferrero S, Fiorentino M, Fiorino M, Ganji A, Ghaffarzadehgan K, Going JJ, Ishaq S, Mandolesi A, Mathews S, Maxim R, Mulder CJ, Neefjes-Borst A, Robert M, Russo I, Rostami-Nejad M, Sidoni A, Sotoudeh M, Villanacci V, Volta U, Zali MR, Srivastava A.

Gut. 2017 Dec;66(12):2080-2086. doi: 10.1136/gutjnl-2017-314297. Epub 2017 Sep 11.

18.

Large Cell Neuroendocrine Carcinoma Transformation and EGFR-T790M Mutation as Coexisting Mechanisms of Acquired Resistance to EGFR-TKIs in Lung Cancer.

Baglivo S, Ludovini V, Sidoni A, Metro G, Ricciuti B, Siggillino A, Rebonato A, Messina S, Crinò L, Chiari R.

Mayo Clin Proc. 2017 Aug;92(8):1304-1311. doi: 10.1016/j.mayocp.2017.03.022.

PMID:
28778263
19.

Influence of chemotherapeutic drug-related gene polymorphisms on toxicity and survival of early breast cancer patients receiving adjuvant chemotherapy.

Ludovini V, Antognelli C, Rulli A, Foglietta J, Pistola L, Eliana R, Floriani I, Nocentini G, Tofanetti FR, Piattoni S, Minenza E, Talesa VN, Sidoni A, Tonato M, Crinò L, Gori S.

BMC Cancer. 2017 Jul 26;17(1):502. doi: 10.1186/s12885-017-3483-2.

20.

WITHDRAWN: Nephrotic syndrome in primary myelofibrosis with renal extramedullary hematopoiesis and glomerulopathy in the JAK inhibitor era.

Sordo RD, Brugnano R, Covarelli C, Fiorucci G, Falzetti F, Barbatelli G, Nunzi E, Sidoni A.

Clin Nephrol. 2017 Jul 24. doi: 10.5414/CNCS109100. [Epub ahead of print]

PMID:
28737134
21.

Nonalcoholic fatty liver disease impairs the cytochrome P-450-dependent metabolism of α-tocopherol (vitamin E).

Bartolini D, Torquato P, Barola C, Russo A, Rychlicki C, Giusepponi D, Bellezza G, Sidoni A, Galarini R, Svegliati-Baroni G, Galli F.

J Nutr Biochem. 2017 Sep;47:120-131. doi: 10.1016/j.jnutbio.2017.06.003. Epub 2017 Jun 7.

PMID:
28628909
22.

Erratum to: Elaboration of a nomogram to predict nonsentinel node status in breast cancer patients with positive sentinel node, intraoperatively assessed with one step nucleic amplification: Retrospective and validation phase.

Di Filippo F, Di Filippo S, Ferrari AM, Antonetti R, Battaglia A, Becherini F, Bernet L, Boldorini R, Bouteille C, Buglioni S, Burelli P, Cano R, Canzonieri V, Chiodera P, Cirilli A, Coppola L, Drago S, Di Tommaso L, Fenaroli P, Franchini R, Gianatti A, Giannarelli D, Giardina C, Godey F, Grassi MM, Grassi GB, Laws S, Massarut S, Naccarato G, Natalicchio MI, Orefice S, Palmieri F, Perin T, Roncella M, Roncalli MG, Rulli A, Sidoni A, Tinterri C, Truglia MC, Sperduti I.

J Exp Clin Cancer Res. 2017 May 16;36(1):69. doi: 10.1186/s13046-017-0540-2. No abstract available.

23.

Glyoxalase 2 drives tumorigenesis in human prostate cells in a mechanism involving androgen receptor and p53-p21 axis.

Antognelli C, Ferri I, Bellezza G, Siccu P, Love HD, Talesa VN, Sidoni A.

Mol Carcinog. 2017 Sep;56(9):2112-2126. doi: 10.1002/mc.22668. Epub 2017 May 15.

PMID:
28470764
24.

Mitotic index matter: how to improve the assessment of mitosis in order to better classify G2 breast cancer and luminal A category.

Del Sordo R, Bellezza G, Ferri I, Pireddu A, Colella R, Sidoni A.

Histol Histopathol. 2018 Jan;33(1):81-88. doi: 10.14670/HH-11-891. Epub 2017 Mar 23.

PMID:
28332699
25.

Biparametric versus Multiparametric MRI with Non-endorectal Coil at 3T in the Detection and Localization of Prostate Cancer.

Scialpi M, Prosperi E, D'Andrea A, Martorana E, Malaspina C, Palumbo B, Orlandi A, Falcone G, Milizia M, Mearini L, Aisa MC, Scialpi P, DE Dominicis C, Bianchi G, Sidoni A.

Anticancer Res. 2017 Mar;37(3):1263-1271. Erratum in: Anticancer Res. 2017 Jul;37(7):3981.

PMID:
28314291
26.

Autoimmune gastritis: relationships with anemia and Helicobacter pylori status.

Villanacci V, Casella G, Lanzarotto F, Di Bella C, Sidoni A, Cadei M, Salviato T, Dore MP, Bassotti G.

Scand J Gastroenterol. 2017 Jun - Jul;52(6-7):674-677. doi: 10.1080/00365521.2017.1288758. Epub 2017 Feb 17.

PMID:
28276835
27.

Elaboration of a nomogram to predict nonsentinel node status in breast cancer patients with positive sentinel node, intraoperatively assessed with one step nucleic amplification: Retrospective and validation phase.

Di Filippo F, Di Filippo S, Ferrari AM, Antonetti R, Battaglia A, Becherini F, Bernet L, Boldorini R, Bouteille C, Buglioni S, Burelli P, Cano R, Canzonieri V, Chiodera P, Cirilli A, Coppola L, Drago S, Di Tommaso L, Fenaroli P, Franchini R, Gianatti A, Giannarelli D, Giardina C, Godey F, Grassi MM, Grassi GB, Laws S, Massarut S, Naccarato G, Natalicchio MI, Orefice S, Palmieri F, Perin T, Roncella M, Roncalli MG, Rulli A, Sidoni A, Tinterri C, Truglia MC, Sperduti I.

J Exp Clin Cancer Res. 2016 Dec 8;35(1):193. doi: 10.1186/s13046-016-0460-6. Erratum in: J Exp Clin Cancer Res. 2017 May 16;36(1):69.

28.

Glyoxalase 2 Is Involved in Human Prostate Cancer Progression as Part of a Mechanism Driven By PTEN/PI3K/AKT/mTOR Signaling With Involvement of PKM2 and ERα.

Talesa VN, Ferri I, Bellezza G, Love HD, Sidoni A, Antognelli C.

Prostate. 2017 Feb;77(2):196-210. doi: 10.1002/pros.23261. Epub 2016 Oct 3.

PMID:
27696457
29.

Aberrant Pattern of Cytokeratin Expression in Olfactory Neuroblastoma: A Potential Diagnostic Pitfall.

Mandarano M, Colella R, Giansanti M, Sidoni A.

Head Neck Pathol. 2017 Jun;11(2):262-263. doi: 10.1007/s12105-016-0743-4. Epub 2016 Jul 8. No abstract available.

30.

e-Cadherin in 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-Induced Parkinson Disease.

Cataldi S, Codini M, Hunot S, Légeron FP, Ferri I, Siccu P, Sidoni A, Ambesi-Impiombato FS, Beccari T, Curcio F, Albi E.

Mediators Inflamm. 2016;2016:3937057. doi: 10.1155/2016/3937057. Epub 2016 Apr 17.

31.

The enteric nervous system in patients with calculous and acalculous gallbladder.

Villanacci V, Del Sordo R, Salemme M, Cadei M, Sidoni A, Bassotti G.

Dig Liver Dis. 2016 Jul;48(7):792-5. doi: 10.1016/j.dld.2016.03.014. Epub 2016 Mar 26.

PMID:
27068404
32.

Survival outcomes and incidence of brain recurrence in high-grade neuroendocrine carcinomas of the lung: Implications for clinical practice.

Metro G, Ricciuti B, Chiari R, Baretti M, Falcinelli L, Giannarelli D, Sidoni A, Mountzios G, Crinò L, Bellezza G, Rebonato A, Ferolla P, Toschi L.

Lung Cancer. 2016 May;95:82-7. doi: 10.1016/j.lungcan.2016.03.006. Epub 2016 Mar 15.

PMID:
27040856
33.

High expression of cellular retinol binding protein-1 in lung adenocarcinoma is associated with poor prognosis.

Doldo E, Costanza G, Ferlosio A, Pompeo E, Agostinelli S, Bellezza G, Mazzaglia D, Giunta A, Sidoni A, Orlandi A.

Genes Cancer. 2015 Nov;6(11-12):490-502.

34.

Myenteric plexitis: A frequent feature in patients undergoing surgery for colonic diverticular disease.

Bassotti G, Villanacci V, Sidoni A, Nascimbeni R, Dore MP, Binda GA, Bandelloni R, Salemme M, Del Sordo R, Cadei M, Manca A, Bernardini N, Maurer CA, Cathomas G.

United European Gastroenterol J. 2015 Dec;3(6):523-8. doi: 10.1177/2050640614563822.

35.

The Tm7sf2 Gene Deficiency Protects Mice against Endotoxin-Induced Acute Kidney Injury.

Gatticchi L, Bellezza I, Del Sordo R, Peirce MJ, Sidoni A, Roberti R, Minelli A.

PLoS One. 2015 Nov 5;10(11):e0141885. doi: 10.1371/journal.pone.0141885. eCollection 2015.

36.

Functional signaling pathway analysis of lung adenocarcinomas identifies novel therapeutic targets for KRAS mutant tumors.

Baldelli E, Bellezza G, Haura EB, Crinó L, Cress WD, Deng J, Ludovini V, Sidoni A, Schabath MB, Puma F, Vannucci J, Siggillino A, Liotta LA, Petricoin EF 3rd, Pierobon M.

Oncotarget. 2015 Oct 20;6(32):32368-79. doi: 10.18632/oncotarget.5941.

37.

miRNAs and resistance to EGFR-TKIs in EGFR-mutant non-small cell lung cancer: beyond 'traditional mechanisms' of resistance.

Ricciuti B, Mecca C, Cenci M, Leonardi GC, Perrone L, Mencaroni C, Crinò L, Grignani F, Baglivo S, Chiari R, Sidoni A, Paglialunga L, Currà MF, Murano E, Minotti V, Metro G.

Ecancermedicalscience. 2015 Sep 2;9:569. doi: 10.3332/ecancer.2015.569. eCollection 2015.

38.

IMP3 Is Strongly Expressed in Malignant Phyllodes Tumors of the Breast: An Immunohistochemical Study.

Bellezza G, Prosperi E, Del Sordo R, Colella R, Rulli A, Sidoni A.

Int J Surg Pathol. 2016 Feb;24(1):37-42. doi: 10.1177/1066896915603119. Epub 2015 Sep 9.

PMID:
26353850
39.

Molecular Cytogenetics Detect an Unbalanced t(2;13)(q36;q14) and PAX3-FOXO1 Fusion in Rhabdomyosarcoma With Mixed Embryonal/Alveolar Features.

La Starza R, Nofrini V, Pierini T, Pierini V, Zin A, Bisogno G, Cerri C, Caniglia M, Sidoni A, Ludwig K, Mecucci C.

Pediatr Blood Cancer. 2015 Dec;62(12):2238-41. doi: 10.1002/pbc.25664. Epub 2015 Jul 14.

PMID:
26179572
40.

Artesunate induces ROS- and p38 MAPK-mediated apoptosis and counteracts tumor growth in vivo in embryonal rhabdomyosarcoma cells.

Beccafico S, Morozzi G, Marchetti MC, Riccardi C, Sidoni A, Donato R, Sorci G.

Carcinogenesis. 2015 Sep;36(9):1071-83. doi: 10.1093/carcin/bgv098. Epub 2015 Jul 7.

PMID:
26153023
41.

Progesterone receptor status and clinical outcome in breast cancer patients with estrogen receptor-positive locoregional recurrence.

Bogina G, Lunardi G, Coati F, Zamboni G, Gori S, Bortesi L, Marconi M, Cassandrini PA, Turazza M, Cortesi L, DeMatteis E, Ficarra G, Ibrahim T, Serra P, Medri L, Giraudi S, Lambertini M, Carli F, Foglietta J, Sidoni A, Nunzi M, Ficorella C, Diadema MR, Del Mastro L.

Tumori. 2015 Jul-Aug;101(4):398-403. doi: 10.5301/tj.5000323. Epub 2015 May 22.

PMID:
26045108
42.

KIT, PDGFRA, and BRAF mutational spectrum impacts on the natural history of imatinib-naive localized GIST: a population-based study.

Rossi S, Gasparotto D, Miceli R, Toffolatti L, Gallina G, Scaramel E, Marzotto A, Boscato E, Messerini L, Bearzi I, Mazzoleni G, Capella C, Arrigoni G, Sonzogni A, Sidoni A, Mariani L, Amore P, Gronchi A, Casali PG, Maestro R, Dei Tos AP.

Am J Surg Pathol. 2015 Jul;39(7):922-30. doi: 10.1097/PAS.0000000000000418.

PMID:
25970686
43.

MYC and human telomerase gene (TERC) copy number gain in early-stage non-small cell lung cancer.

Flacco A, Ludovini V, Bianconi F, Ragusa M, Bellezza G, Tofanetti FR, Pistola L, Siggillino A, Vannucci J, Cagini L, Sidoni A, Puma F, Varella-Garcia M, Crinò L.

Am J Clin Oncol. 2015 Apr;38(2):152-8. doi: 10.1097/COC.0000000000000012.

44.

The loss of Tm7sf gene accelerates skin papilloma formation in mice.

Bellezza I, Gatticchi L, del Sordo R, Peirce MJ, Sidoni A, Roberti R, Minelli A.

Sci Rep. 2015 Mar 25;5:9471. doi: 10.1038/srep09471.

45.

Future options for ALK-positive non-small cell lung cancer.

Iacono D, Chiari R, Metro G, Bennati C, Bellezza G, Cenci M, Ricciuti B, Sidoni A, Baglivo S, Minotti V, Crinò L.

Lung Cancer. 2015 Mar;87(3):211-9. doi: 10.1016/j.lungcan.2014.12.017. Epub 2015 Jan 3. Review.

PMID:
25601484
46.

Metachronous cardiac and cerebral sarcomas: case report with focus on molecular findings and review of the literature.

Guerriero A, Giovenali P, La Starza R, Mecucci C, Montesi G, Pasquino S, Pierini T, Ragni T, Sidoni A.

Hum Pathol. 2015 Mar;46(3):482-7. doi: 10.1016/j.humpath.2014.10.028. Epub 2014 Dec 9. Review.

PMID:
25586016
47.

Prognostic impact of alternative splicing-derived hMENA isoforms in resected, node-negative, non-small-cell lung cancer.

Bria E, Di Modugno F, Sperduti I, Iapicca P, Visca P, Alessandrini G, Antoniani B, Pilotto S, Ludovini V, Vannucci J, Bellezza G, Sidoni A, Tortora G, Radisky DC, Crinò L, Cognetti F, Facciolo F, Mottolese M, Milella M, Nisticò P.

Oncotarget. 2014 Nov 30;5(22):11054-63.

48.

Discordance rate of HER2 status in primary breast carcinomas versus synchronous axillary lymph node metastases: a multicenter retrospective investigation.

Ieni A, Barresi V, Caltabiano R, Cascone AM, Del Sordo R, Cabibi D, Zeppa P, Lanzafame S, Sidoni A, Franco V, Tuccari G.

Onco Targets Ther. 2014 Jul 11;7:1267-72. doi: 10.2147/OTT.S65294. eCollection 2014.

49.

An additional case of breast tumor resembling the tall cell variant of papillary thyroid carcinoma.

Colella R, Guerriero A, Giansanti M, Sidoni A, Bellezza G.

Int J Surg Pathol. 2015 May;23(3):217-20. doi: 10.1177/1066896914536222. Epub 2014 May 26.

PMID:
24868004
50.

NEDD4 controls the expression of GUCD1, a protein upregulated in proliferating liver cells.

Bellet MM, Piobbico D, Bartoli D, Castelli M, Pieroni S, Brunacci C, Chiacchiaretta M, Del Sordo R, Fallarino F, Sidoni A, Puccetti P, Romani L, Servillo G, Della Fazia MA.

Cell Cycle. 2014;13(12):1902-11. doi: 10.4161/cc.28760. Epub 2014 Apr 17.

Supplemental Content

Loading ...
Support Center